Subcutaneous fentanyl infusion in a patient with bowel obstruction and renal failure

被引:26
作者
Mercadante, S
Caligara, R
Sapio, M
Serretta, R
Lodi, F
机构
[1] INST TOXICOL,MILAN,ITALY
[2] BUCCHERI LA FERLA FATEBENEFRATELLI HOSP,DEPT ANESTHESIA & INTENS CARE,PALERMO,ITALY
关键词
cancer pain; bowed obstruction; renal failure; morphine metabolites; fentanyl;
D O I
10.1016/S0885-3924(97)00076-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Inoperable bowel obstruction in patients with renal failure is a difficult clinical situation. In the last days of life, an accumulation of morphine metabolites in patients with impaired renal function may cause opioid toxicity, including terminal agitation. The use of an alternative drug may prevent morphine metabolite accumulation in uremic patients Fentanyl may be an alternative to morphine. It has a large apparent volume of distribution, a short plasma half-life, and extensive biotransformation without active metabolites. A patient with acute renal impairment and bowel obstruction was successfully treated with a subcutaneous continuous infusion of fentanyl (25 mu g/hr) and boluses of 12.5 mu g for the last 2 days of life, limiting the worsening of the dramatic clinical picture of bowel obstruction combined with renal impairment. No local toxicity was evidenced. (C) S. Mercadante, 1997.
引用
收藏
页码:241 / 244
页数:4
相关论文
共 15 条
[1]  
BRUERA E, 1988, CANCER-AM CANCER SOC, V62, P407, DOI 10.1002/1097-0142(19880715)62:2<407::AID-CNCR2820620227>3.0.CO
[2]  
2-T
[3]   PLASMA AND CEREBROSPINAL-FLUID CONCENTRATIONS OF MORPHINE AND MORPHINE GLUCURONIDES AFTER ORAL MORPHINE - THE INFLUENCE OF RENAL-FAILURE [J].
DHONNEUR, G ;
GILTON, A ;
SANDOUK, P ;
SCHERRMANN, JM ;
DUVALDESTIN, P .
ANESTHESIOLOGY, 1994, 81 (01) :87-93
[4]   AN OPEN LABEL STUDY OF ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC) FOR THE TREATMENT OF BREAKTHROUGH CANCER PAIN [J].
FINE, PG ;
MARCUS, M ;
DEBOER, AJ ;
VANDEROORD, B .
PAIN, 1991, 45 (02) :149-153
[5]  
GONG QL, 1992, PAIN, V48, P249, DOI 10.1016/0304-3959(92)90065-J
[6]   CHRONIC NAUSEA AND MORPHINE-6-GLUCURONIDE [J].
HAGEN, NA ;
FOLEY, KM ;
CERBONE, DJ ;
PORTENOY, RK ;
INTURRISI, CE .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1991, 6 (03) :125-128
[7]  
JAFFE JH, 1985, PHARMACOL BASIS THER, P517
[8]  
Kirkham S R, 1995, Lancet, V345, P1185, DOI 10.1016/S0140-6736(95)91019-0
[9]   DETERMINATION OF FENTANYL AND ALFENTANIL IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION [J].
KUMAR, K ;
MORGAN, DJ ;
CRANKSHAW, DP .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 419 :464-468
[10]  
MERCADANTE S, 1995, PAIN DIGEST, V5, P9